BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND BCL2, Bcl-2, 596, ENSG00000171791 AND Treatment
232 results:

  • 1. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
    Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
    [No Abstract]    [Full Text] [Related]  

  • 2. In Doxorubicin-Adapted hodgkin lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869.
    Casagrande N; Borghese C; Avanzo M; Aldinucci D
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067159
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. treatment of older patients with mantle cell lymphoma in the era of novel agents.
    Rozental A; Jim HSL; Extermann M
    Leuk Lymphoma; 2023 Sep; 64(9):1514-1526. PubMed ID: 37357622
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Myc rearrangement and concurrent high protein expression of C-Myc/bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma.
    Wang X; He J; He H; Shuai Y; Wang L; Li Y; Huang Y; Yu K; Zhao M; Xie T; Li D
    Ann Diagn Pathol; 2023 Oct; 66():152165. PubMed ID: 37348414
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or bcl-2 targeting.
    Mhibik M; Gaglione EM; Eik D; Herrick J; Le J; Ahn IE; Chiu C; Wielgos-Bonvallet M; Hiemstra IH; Breij ECW; Chen J; Reilly EB; Epling-Burnette PK; Szafer-Glusman E; Sun C; Wiestner A
    Blood Adv; 2023 Aug; 7(15):4089-4101. PubMed ID: 37219524
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: A case report and brief review of the literature.
    Cristian M; Baz RA; Stoica AG; Așchie M; Ghinea MM; Deacu M; Boșoteanu M; Mitroi AF; Dobrin N; Iordache IE; Bălțătescu GI
    Medicine (Baltimore); 2023 Feb; 102(8):e33083. PubMed ID: 36827036
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diffuse large B-cell lymphoma involving multiple immunoprivileged sites presenting as painful ophthalmoplegia: A case report.
    Zhang Y; Jianfeng Z
    Medicine (Baltimore); 2023 Jan; 102(3):e32695. PubMed ID: 36701728
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Efficacy Analysis of Bendamustine-Based Combination Regimen in treatment of Patients with Relapsed/Refractory Non-hodgkin lymphoma].
    Guo YT; Li F; Dong WM; Lin Y; Xie XB; Ling Y; Yan F; Hua XY; He B; Gu WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1766-1771. PubMed ID: 36476901
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Navitoclax Most Promising BH3 Mimetic for Combination Therapy in hodgkin lymphoma.
    Langendonk M; Smit NAM; Plattel W; Diepstra A; Meerten TV; Visser L
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430230
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. treatment of relapsed and refractory Waldenstrom Macroglobulinemia.
    Amaador K; Kersten MJ; Minnema MC; Vos JMI
    Leuk Lymphoma; 2023 Jan; 64(1):30-41. PubMed ID: 36282673
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High plasma EBV-DNA load and positive EBER status associated with viral recurrence and persistent infection in early treatment of lymphoma.
    Zeng M; Jia Q; Chen J; Xu L; Xie L; Cheng Q; Li Q; Xiao M; Fang Z
    Clin Exp Med; 2023 Aug; 23(4):1307-1316. PubMed ID: 36168074
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Nodular lymphocyte predominant hodgkin lymphoma (paragranuloma of Poppema) in children: Case report, review of the literature and treatment].
    Wilgenhof K; Théate I; Devalck C; Forsyth R; Dehou MF
    Ann Pathol; 2023 Jan; 43(1):39-44. PubMed ID: 36008237
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. treatment strategies for patients with diffuse large B-cell lymphoma.
    Poletto S; Novo M; Paruzzo L; Frascione PMM; Vitolo U
    Cancer Treat Rev; 2022 Nov; 110():102443. PubMed ID: 35933930
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy.
    Diamond JR; Boni V; Lim E; Nowakowski G; Cordoba R; Morillo D; Valencia R; Genvresse I; Merz C; Boix O; Frigault MM; Greer JM; Hamdy AM; Huang X; Izumi R; Wong H; Moreno V
    Clin Cancer Res; 2022 Apr; 28(7):1285-1293. PubMed ID: 35046056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
    Chiappella A; Diop F; Agostinelli C; Novo M; Nassi L; Evangelista A; Ciccone G; Di Rocco A; Martelli M; Melle F; Moia R; Motta G; Righi S; Santambrogio E; Tucci A; Balzarotti M; Ladetto M; Pileri SA; Gaidano G; Vitolo U;
    Br J Haematol; 2022 Mar; 196(5):1184-1193. PubMed ID: 34951009
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Does MRD have a role in the management of iNHL?
    Giudice ID; Starza ID; Foà R
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):320-330. PubMed ID: 34889425
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Blastoid variant of mantle cell lymphoma in palatine tonsil.
    Valente VB; de Castro TF; Takamiya AS; Callestini R; Xavier-Junior JCC; Cortopassi GM; Neto SC; Collado FU; Biasoli ÉR; Miyahara GI; Bernabé DG
    Oral Oncol; 2021 Nov; 122():105552. PubMed ID: 34610523
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Gonzalez de Villambrosia S; Bastos M; Palanca JM; Cruz JG; Navarro JT; Tapia G; Alonso SA; Martin A; Blanco O; Abrisqueta P; Castellvi J; García-Noblejas A; Arranz R; Adrados M; López A; Montes-Moreno S;
    Leuk Lymphoma; 2022 Jan; 63(1):101-108. PubMed ID: 34510996
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
    Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
    Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.